CENTRAL LINE BLOOD CULTURE DRA — Class II medical device recall Z-0312-2024
Ongoing recall by MEDLINE INDUSTRIES, LP - Northfield, reported 2023-11-22, distributed nationwide. This recall is being issued due to items within the kit have expired prior to the overall kit expiration date
| Recall number | Z-0312-2024 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | MEDLINE INDUSTRIES, LP - Northfield, Northfield, IL, United States |
| Recall initiated | 2023-11-01 |
| Classified | 2023-11-16 |
| Reported by FDA | 2023-11-22 |
| Distributed | Nationwide (US) |
| Quantity | 1,600 kits |
| UPC / GTIN / UDI-DI | 10193489402445, 40193489402446 |
| Lot numbers | 23CMD955, 23CMH030, 23DMF156 |
| Model numbers | DYNDH1562 |
Product
CENTRAL LINE BLOOD CULTURE DRA, REF DYNDH1562
Reason for recall
This recall is being issued due to items within the kit have expired prior to the overall kit expiration date listed on the insert.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0312-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.